MarketWatch (press release) What does the future hold for companies of the in vitro diagnostics (IVD) industry? Visiongain's new report shows you their prospects to 2023. There you see financial results, trends, opportunities and ... 更多 »
FierceBiotech Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche's personalised healthcare strategy aims at providing ... 更多 »
PharmiWeb.com (press release) Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics and a frontrunner in diabetes management. Roche's personalised healthcare strategy aims at providing ... 更多 »
Mideast Time DiaSorin SpA, based in Italy, provides medical diagnostic equipment. The Company develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious ...
Sacramento Bee ... of ACS and suspected ACS patients still visit emergency rooms every year with symptoms such as chest pain, and these patients are typically assessed with in vitro diagnostic cardiac biomarker tests. 更多 »
Sacramento Bee Summary The ACS in vitro diagnostics market is dominated by a single biomarker test, cardiac troponins. However, this market remains of high interest due to advancements in assay sensitivity both on ... 更多 »
The Herald | HeraldOnline.com The Indian IVD market is valued at more than US$ 500 Million, and is expected to touch the US$ 1 Billion in 2016 growing steady at a CAGR of 19%. This remarkable growth can be attributed to ...
Mideast Time Adjusted revenues climbed 12.3% to $13.7 million driven by increased sales of vitro diagnostics offerings and hydrophilic coatings. We are positive on the sale of SurModics Pharmaceuticals unit as this ... 更多 »
